Biotechnology News

August 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix expands QuantiGene ViewRNA license with Siemens for in vitro diagnostics using in situ hybridization.

August 1, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Expiration of the
Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, Inc.

August 1, 2012

PLEASANTON, Calif.--(BUSINESS WIRE)--Analyst Study Concludes Veeva Systems is the Leading CRM System Provider to the U.S. Pharmaceutical Industry

August 1, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it will host a...

August 1, 2012

NEW YORK--(BUSINESS WIRE)--New York Genome Center (NYGC) today announced the launch of its Innovation Center, which will provide access to new sequencing technologies and foster collaboration among NYGC’s Institutional Founding Members (IFMs) and...

August 1, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, will present at the upcoming Wedbush PacGrow LifeSciences...

August 1, 2012

LONDON--(BUSINESS WIRE)--New market report “China Genetic Engineering Drug Industry Report, 2011-2012” worked out by ResearchInChina has been recently published by Market Publishers Ltd.

August 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent completes its acquisition of Asterand Human Tissue Business. The purchase is a step in Stemgent's strategy to build a research tools business focused on human cells for R&D and drug discovery

August 1, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--MDxHealth, a developer of epigenetic tests for cancer, has received CAP accreditation for its Irvine lab. The first product offered is the recently launched ConfirmMDx™ for Prostate Cancer...

August 1, 2012

BURLINGTON, Ontario--(BUSINESS WIRE)--Clinical findings show the innovative Canadian delivra™ system penetrates into the skin and muscle 687% deeper than the ingredients in leading topical creams.

July 31, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, announced...

July 31, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) will release its 2012 second quarter financial results on Tuesday, August 7, 2012 and its management will host a conference call to discuss the second quarter financial...

July 31, 2012

LAKE ZURICH, Ill. & WORCESTER, Mass.--(BUSINESS WIRE)--Experts call for new steps to improve platelet safety, including the use of the Verax Platelet PGD® test administered at hospitals prior to transfusion.

July 31, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE: NAVB) Completes License for Parkinson's Disease Imaging Agent with Alseres: Adds second promising neuroimaging candidate to growing pipeline

July 31, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will report its second quarter 2012 financial results on August 7, 2012, after close of market.

July 31, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. (NASDAQ:HPTX) announced today the completion of its initial public offering of 5,000,000 shares of common stock. In addition, the underwriters of its initial public...

July 31, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (NASDAQ: TRNS) (“Transcat” or the “Company”), a leading distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair,...

July 31, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Q2 Earnings Release

July 31, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (NVDL.PK) reports unaudited financial results for the six months ended June 30, 2012.

July 31, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) today announced that patient enrollment has begun in the first Phase 3 clinical trial of BromSite™ (ISV-303) for the reduction of pain and inflammation after cataract...

July 31, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter ended June 30, 2012. Total revenues for the second quarter of 2012 were $1.8 million, a decrease of $1.3 million from the...

July 31, 2012

BOULDER, Colo.--(BUSINESS WIRE)--ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe pain.

July 31, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2012. Total revenue for the quarter was $66.4 million, including approximately $1.4 million in revenue from...

July 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the second quarter ending June 30, 2012 on Monday, August 6, 2012,...

July 31, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--MedtechWomen today announced that registration is now open for MedtechVision 2012: The Empowered Patient, the second annual conference designed by and for women on the forefront of medical innovation. The...

July 31, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Intermountain Healthcare today announced a joint effort with GE Healthcare to help further reduce radiation dose in Computed Tomography (CT) procedures at its facilities by up to 50 percent*.

July 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Prosetta Antiviral Inc today announced the execution of a strategic alliance with Bristol-Myers Squibb Company (NYSE: BMY) to further discover and develop select drug candidates representing new, novel classes of...

July 31, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is excited to announce the finalization of a deal with German botanical...

July 31, 2012

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Tymora Analytical Operations has started to generate revenue from its PolyMAC drug development technology thanks to funding from National Science Foundation and Purdue's Emerging Innovations Fund.

July 31, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD Earns Highest Ratings for Customer Loyalty and Overall Value Among Phase I Providers in ISR Report

July 31, 2012

CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--BioPharm America™, to be held September 19–21, 2012 in Boston, MA has an unprecedented program line-up featuring top CEOs for what will be the most influential US life science partnering event of...

July 31, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--The headline and first graph of the release should read Wednesday, August 8th (sted: Thursday, August 8th). The corrected release reads: ADVANCED CELL TECHNOLOGY TO ANNOUNCE SECOND QUARTER FINANCIAL RESULTS ON...

July 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anchor Therapeutics has entered into a research collaboration with Kyowa Hakko Kirin for Anchor's pepducin technology.

July 31, 2012

NEW YORK--(BUSINESS WIRE)--The International AIDS Vaccine Initiative (IAVI) today announced the appointment to its Board of Directors of Alice P. Albright and Dr. Purnima Mane.

July 31, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics to Extend Warrant Expiry date

July 31, 2012

BOSTON--(BUSINESS WIRE)--Highland Instruments, Inc., Announces Award of Small Business Innovation Research (“SBIR”) Grant for Clinical Evaluation of Non-Invasive Brain Stimulation Technologies.

July 31, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech is hosting a three-part series of free, educational webinars spanning several weeks in August 2012. This webinar series is ideal for healthcare, medical device organizations and physician practice...

July 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced that FG-3019, the Company’s human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug...

July 31, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife’s subsidiary in the U.S.A., Vitrolife, Inc, has together with Southwest Transplant Alliance and University of Texas been sued for compensation by relatives to a patient who deceased...

July 31, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Labcyte has announced that The Institute of Cancer Research (ICR) has implemented its Access™ Laboratory Workstation to automate the production of low-volume, assay-ready microplates.

July 31, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics and Advanced Liquid Logic Finalize Technology and Collaboration Agreements to Develop an All-Digital Fully Integrated Diagnostic Platform

July 31, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it will report financial results for the second quarter of 2012 on...

July 31, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the quarter ended June 30, 2012, on Thursday, August 9, 2012 at approximately 4:00 p.m. ET / 1:00 p.m. PT. The announcement will be...

July 31, 2012

SAN ANTONIO--(BUSINESS WIRE)--GenSpera approved by FDA to initiate G-202 PhaseII trial in prostate cancer.

July 31, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc., a specialty pharmaceutical company, today announced the appointment of Robert Rosen to its board of directors.

July 31, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that it will host a teleconference and webcast with management to provide a general business overview, as well as to discuss its second quarter 2012 financial...